Milestone Scientific Inc. (NYSE:MLSS) Director Michael Mcgeehan Sells 20,000 Shares

Milestone Scientific Inc. (NYSE:MLSS) Director Michael Mcgeehan sold 20,000 shares of Milestone Scientific stock in a transaction dated Thursday, December 19th. The stock was sold at an average price of $0.78, for a total value of $15,600.00. Following the completion of the transaction, the director now directly owns 575,273 shares of the company’s stock, valued at approximately $448,712.94. This trade represents a 3.36 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Michael Mcgeehan also recently made the following trade(s):

• On Tuesday, September 24th, Michael Mcgeehan sold 209 shares of Milestone Scientific stock. The shares were sold at an average price of $1.00, for a total value of $209.00.

Milestone Scientific Price Performance

MLSS stock opened at $0.93 on Monday. The company’s 50-day moving average is $0.81 and its 200-day moving average is $0.86. The stock has a market capitalization of $72.05 million, a PE ratio of -13.21 and a beta of 1.10. Milestone Scientific Inc. has a 1 year low of $0.52 and a 1 year high of $1.10.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Benchmark reiterated a “speculative buy” rating and issued a $1.25 target price on shares of Milestone Scientific in a report on Wednesday, November 20th. StockNews.com initiated coverage on shares of Milestone Scientific in a research note on Friday. They issued a “hold” rating for the company.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in MLSS. Geode Capital Management LLC grew its stake in Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after acquiring an additional 31,572 shares during the period. Y Intercept Hong Kong Ltd bought a new position in shares of Milestone Scientific in the 3rd quarter worth $48,000. Finally, World Investment Advisors LLC acquired a new stake in Milestone Scientific in the 3rd quarter valued at $91,000. Institutional investors own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.